Herzinsuffizienz

Schlüsselwörter

Herzinsuffizienz - Kardiale Resynchronisationstherapie

Keywords

heart failure - cardiac resynchronization therapy

Literatur

• 1 Anker S D, Comin Colet J, Filippatos G. et al . Ferric carboxymaltose in patients with heart failure and iron deficiency.  N Engl J Med. 2009;  361 2436-2448
• 2 Bardy G H, Lee K L, Mark D B. et al . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.  N Engl J Med. 2005;  352 225-237
• 3 Bhatia R S, Tu J V, Lee D S. et al . Outcome of heart failure with preserved ejection fraction in a population-based study.  N Engl J Med. 2006;  355 260-269
• 4 Böhm M, Swedberg K, Komajda M. et al . Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.  Lancet. 2010;  376 886-894
• 5 Cleland J G, Daubert J C, Erdmann E. et al . The effect of cardiac resynchronization on morbidity and mortality in heart failure.  N Engl J Med. 2005;  352 1539-1549
• 6 Dickstein K, Cohen-Solal A, Filippatos G. et al . ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).  Eur Heart J. 2008;  29 939-989
• 7 Dickstein K, Vardas P E, Auricchio A. et al . 2010 Focused Update of ESC Guidelines on device therapy in heart failure.  Eur Heart J. 2010;  31 2677-2687
• 8 Granger C B, McMurray J J, Yusuf S. et al . Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial.  Lancet. 2003;  362 772-776
• 9 Lainscak M, Anker S D. Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.  Herz. 2009;  34 141-147
• 10 Moss A J, Zareba W, Hall W J. et al . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.  N Engl J Med. 2002;  346 877-883
• 11 Neumann T, Biermann J, Erbel R. et al . Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives.  Dtsch Arztebl Int. 2009;  106 269-275
• 12 Pfeffer M A, McMurray J J, Velazquez E J. et al . Valsartan, Captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.  N Engl J Med. 2003;  349 1893-1906
• 13 Pitt B, Remme W, Zannad F. et al . Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.  N Engl J Med. 2003;  348 1309-1321
• 14 Pitt B, Zannad F, Remme W J. et al . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.  N Eng J Med. 1999;  341 709-717
• 15 Sipahi I, Debanne S M, Rowland D Y. et al . Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.  Lancet Oncol. 2010;  11 627-636
• 16 Störk S, Faller H, Schowalter M. et al . Evidenz-basiertes Krankheitsmanagement bei Herzinsuffizienz (HeartNetCare-HF Würzburg).  Dtsch Med Wochenschr. 2009;  134 773-776
• 17 Störk S, Hense H W, Zentgraf C. et al . Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.  Eur J Heart Fail. 2008;  10 1236-1245
• 18 Swedberg K, Komajda M, Böhm M. et al . Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.  Lancet. 2010;  376 875-885
• 19 Tang A S, Wells G A, Talajic M. et al . Cardiac-resynchronization therapy for mild-to-moderate heart failure.  N Engl J Med. 2010;  363 2385-2395
• 20 The SOLVD Investigators . Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.  New Engl J Med. 1991;  325 293-302
• 21 Zannad F, McMurray J J, Krum H. et al . Eplerenone in patients with systolic heart failure and mild symptoms.  N Engl J Med. 2011;  364 11-21